Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 101Leukemia, Myeloid, Acute 94Myelodysplastic Syndromes 88Lymphoma, Non-Hodgkin 87Leukemia 86Hodgkin Disease 75Leukemia, Lymphocytic, Chronic, B-Cell 70Multiple Myeloma 57Lymphoma, Large B-Cell, Diffuse 57Lymphoma, Follicular 52Lymphoma, Mantle-Cell 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 44Leukemia, Myeloid, Accelerated Phase 43Myeloproliferative Disorders 42Congenital Abnormalities 42Leukemia, Myelomonocytic, Chronic 40Neoplasms, Plasma Cell 39Blast Crisis 38Recurrence 32Dendritic Cell Sarcoma, Interdigitating 32Primary Myelofibrosis 29Anemia, Refractory, with Excess of Blasts 29Myelodysplastic-Myeloproliferative Diseases 26Lymphoma, T-Cell, Cutaneous 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Busulfan × Lymphoid × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡